Center for Medicine in the Public Interest (CMPI) is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media with a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Click here to view CMPI reports on counterfeiting. Click here to read the CMPI testimony Counterfeit Drugs and China.

European Alliance for Access to Safe Medicines (EAASM) is an independent, cross-sector patient safety Alliance campaigning for the exclusion of counterfeit and substandard medicines from the supply chain. Raising public awareness of the issues surrounding counterfeit medicines forms a key part of the activities of the EAASM.

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a non-profit, non-governmental organization representing industry associations from both developed and developing countries. Member companies of the IFPMA are the major global research-based pharmaceutical and vaccine companies.

Medicines and Healthcare products Regulatory Agency (MHRA) is the UK governmental agency which is responsible for ensuring that medicines and medical devices work and are acceptably safe. MHRA and Royal Pharmaceutical Society of Great Britain RPSGB have published anti-counterfeit guidance for both patients and pharmacists; Counterfeit medicines: Guidance for Pharmacists and Counterfeit medicines: Guidance for Patients.

Partnership for Safe Medicines comprises a group of organizations and individuals that have policies, procedures, or programmes to protect consumers from counterfeit or contraband medicines. They have a lot of information on the issues of fakes drugs and how to spot genuine products, and issue alerts as new counterfeit and substandard products are identified on the market.

Pharmaceutical Security Institute (PSI) was established in 2002 by the Security Directors from fourteen major pharmaceutical companies as a not-for-profit corporation based in the Washington, DC metropolitan area. Working with its members PSI has developed improved systems to identify the extent of the problem and to assist in coordinating international inquiries. PSI maintains a close affiliation with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) detailed above. The IFPMA Director-General serves as the PSI President.

US Food and Drug Administration (FDA) is responsible for protecting the public health in the United States by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, food supply, cosmetics, and products that emit radiation. The FDA is very active in disseminating information about counterfeit products in this industry.

World Health Organization (WHO) is the United Nations specialized agency for health and was established on 7 April 1948. Its objective, as set out in its Constitution, is the attainment of the highest possible level of health for all people around the globe. Health is defined in WHO's Constitution as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. As such, it plays a key role in tackling the issues of counterfeit and substandard pharmaceuticals and medical devices.